HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

BACKGROUND: The use and possible effects of factors known to improve outcomes in patients with human immunodeficiency virus associated nephropathy (HIVAN), namely of angiotensin converting enzyme inhibitors (ACE) and antiretroviral therapy, has not been reported for a national sample of dialysis pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbott, Kevin C, Trespalacios, Fernando C, Agodoa, Lawrence Y, Ahuja, Tejinder S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166168/
https://www.ncbi.nlm.nih.gov/pubmed/12837135
http://dx.doi.org/10.1186/1471-2369-4-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC166168/
https://www.ncbi.nlm.nih.gov/pubmed/12837135
http://dx.doi.org/10.1186/1471-2369-4-5

Ejemplares similares